Find the investors funding Health Series A rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Ai3Bio Launches With $48M Series A to Reset Immune System - citybiz.co
Ai3Bio has launched with a $48 million Series A funding round. The company aims to reset the immune system, suggesting a focus on novel therapeutic approaches for immune-related diseases.
Ai3Bio Launches With $48M Series A to Reset Immune System citybiz.co
| Nov 03, 2026 | Clinics On Cloud | $14.4M | — | India |
| Nov 03, 2026 | Zafrens | $6.0M | Series A | United States |
| Nov 03, 2026 | Aioss | $1.1M | Seed | Denmark |
| Nov 02, 2026 | Activ Surgical | $45.0M | Series B | United States |
You just read who funded Ai3Bio. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.